Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 590

1.

Pretreatment pattern of symptom expression in premenstrual dysphoric disorder.

Pearlstein T, Yonkers KA, Fayyad R, Gillespie JA.

J Affect Disord. 2005 Apr;85(3):275-82.

PMID:
15780697
2.

Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase.

Yonkers KA, Pearlstein T, Fayyad R, Gillespie JA.

J Affect Disord. 2005 Apr;85(3):317-21.

PMID:
15780701
3.

Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo.

Pearlstein TB, Halbreich U, Batzar ED, Brown CS, Endicott J, Frank E, Freeman EW, Harrison WM, Haskett RF, Stout AL, Yonkers KA.

J Clin Psychiatry. 2000 Feb;61(2):101-9.

PMID:
10732657
4.

Efficacy and tolerability of premenstrual use of venlafaxine (flexible dose) in the treatment of premenstrual dysphoric disorder.

Cohen LS, Soares CN, Lyster A, Cassano P, Brandes M, Leblanc GA.

J Clin Psychopharmacol. 2004 Oct;24(5):540-3.

PMID:
15349012
5.

Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome.

Halbreich U, Smoller JW.

J Clin Psychiatry. 1997 Sep;58(9):399-402.

PMID:
9378691
6.
7.

A preliminary study of luteal phase versus symptom-onset dosing with escitalopram for premenstrual dysphoric disorder.

Freeman EW, Sondheimer SJ, Sammel MD, Ferdousi T, Lin H.

J Clin Psychiatry. 2005 Jun;66(6):769-73.

PMID:
15960573
8.

[Psychiatric and psychological aspects of premenstrual syndrome].

Limosin F, Ades J.

Encephale. 2001 Nov-Dec;27(6):501-8. Review. French.

PMID:
11865558
9.

[Assessment of premenstrual dysphoric disorder symptoms: population of women in Casablanca].

McHichi alami Kh, Tahiri SM, Moussaoui D, Kadri N.

Encephale. 2002 Nov-Dec;28(6 Pt 1):525-30. French.

PMID:
12506265
10.

Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies.

Kornstein SG, Pearlstein TB, Fayyad R, Farfel GM, Gillespie JA.

J Clin Psychiatry. 2006 Oct;67(10):1624-32.

PMID:
17107257
11.

Treatment of premenstrual dysphoric disorder with selective serotonin reuptake inhibitors.

Luisi AF, Pawasauskas JE.

Pharmacotherapy. 2003 Sep;23(9):1131-40. Review.

PMID:
14524645
12.

Predictors of response to sertraline treatment of severe premenstrual syndromes.

Freeman EW, Sondheimer SJ, Polansky M, Garcia-Espagna B.

J Clin Psychiatry. 2000 Aug;61(8):579-84.

PMID:
10982201
13.

Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial.

Yonkers KA, Kornstein SG, Gueorguieva R, Merry B, Van Steenburgh K, Altemus M.

JAMA Psychiatry. 2015 Oct;72(10):1037-44. doi: 10.1001/jamapsychiatry.2015.1472.

14.

Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study.

Jermain DM, Preece CK, Sykes RL, Kuehl TJ, Sulak PJ.

Arch Fam Med. 1999 Jul-Aug;8(4):328-32.

PMID:
10418540
15.

[Sertraline in the treatment of premenstrual dysphoric disorder].

Culav-Sumić J, Skocilić Z, Jukić V.

Lijec Vjesn. 1999 Jul-Aug;121(7-8):234-8. Croatian.

PMID:
10573958
16.

Intermittent versus continuous sertraline therapy in the treatment of premenstrual dysphoric disorders.

Alpay FB, Turhan NO.

Int J Fertil Womens Med. 2001 Jul-Aug;46(4):228-31.

PMID:
11563834
17.

Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles.

Cohen LS, Soares CN, Otto MW, Sweeney BH, Liberman RF, Harlow BL.

J Affect Disord. 2002 Jul;70(2):125-32.

PMID:
12117624
18.

Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder.

Halbreich U, Bergeron R, Yonkers KA, Freeman E, Stout AL, Cohen L.

Obstet Gynecol. 2002 Dec;100(6):1219-29.

PMID:
12468166
19.
20.

How does premenstrual dysphoric disorder relate to depression and anxiety disorders?

Landén M, Eriksson E.

Depress Anxiety. 2003;17(3):122-9.

PMID:
12768646

Supplemental Content

Support Center